| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:537349569:1938 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:537349569:1938?format=raw |
LEADER: 01938fam a2200421 a 4500
001 3976396
005 20221027012558.0
008 930323t19931993gw a b 001 0 eng c
010 $a 93013134
020 $a3540566694 (alk. paper)
020 $a0387566694 (alk. paper)
035 $a(OCoLC)27974451
035 $a(OCoLC)ocm27974451
035 $9AHK1899HS
035 $a(NNC)3976396
035 $a3976396
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M
050 00 $aRC261$b.R35 no. 129$aRC271.S66
060 0 $aW1 RE106P v. 129 1993$aQZ 267 P4242 1993
082 00 $a616.99/4 s$a616.99/4061$220
245 00 $aPeptides in oncology II :$bsomatostatin analogues and bombesin antagonists /$cK. Höffken, (eds.).
260 $aBerlin ;$aNew York :$bSpringer-Verlag,$c[1993], ©1993.
300 $ax, 136 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aRecent results in cancer research ;$v129
504 $aIncludes bibliographical references and index.
650 0 $aSomatostatin$xDerivatives$xTherapeutic use$xTesting.
650 0 $aBombesin$xAntagonists$xTherapeutic use$xTesting.
650 0 $aCancer$xChemotherapy.$0http://id.loc.gov/authorities/subjects/sh85019497
650 2 $aNeoplasms$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D009369Q000188
650 2 $aSomatostatin$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D013004Q000627
650 2 $aSomatostatin$xanalogs & derivatives.$0https://id.nlm.nih.gov/mesh/D013004Q000031
650 2 $aBombesin$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D001839Q000627
650 2 $aBombesin$xantagonists & inhibitors.$0https://id.nlm.nih.gov/mesh/D001839Q000037
700 1 $aHöffken, K.$q(Klaus),$d1946-$0http://id.loc.gov/authorities/names/n88044934
830 0 $aRecent results in cancer research ;$v129.$0http://id.loc.gov/authorities/names/n42020830
852 00 $boff,hsl$hRC271.S66$iP47 1993